Literature DB >> 9865328

Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.

C R Gregory1, A Stewart, B Sturges, T DeManvelle, A Cannon, T Ortega, M Harb, R E Morris.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9865328     DOI： 10.1016/s0041-1345(98)01373-6

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  10 in total

1.  Efficacy of leflunomide for treatment of immune-mediated polyarthritis in dogs: 14 cases (2006-2008).

Authors:  Sara A Colopy; Theresa A Baker; Peter Muir
Journal:  J Am Vet Med Assoc       Date:  2010-02-01       Impact factor: 1.936

2.  In-vitro immunosuppression of canine T-lymphocyte-specific proliferation with dexamethasone, cyclosporine, and the active metabolites of azathioprine and leflunomide in a flow-cytometric assay.

Authors:  Laura A Nafe; John R Dodam; Carol R Reinero
Journal:  Can J Vet Res       Date:  2014-07       Impact factor: 1.310

Review 3.  A review of immunologic diseases of the dog.

Authors:  N C Pedersen
Journal:  Vet Immunol Immunopathol       Date:  1999-08-02       Impact factor: 2.046

4.  Pharmacodynamic assessment of ex-vivo canine T-lymphocyte proliferation: Responses to dexamethasone, cyclosporine, mycophenolic acid, and the active metabolite of leflunomide.

Authors:  Megan Grobman; Kaitlin A Bishop; Hansjorg Rindt; Laura A Nafe; Carol R Reinero
Journal:  Can J Vet Res       Date:  2019-10       Impact factor: 1.310

5.  Efficacy of leflunomide for treatment of refractory inflammatory colorectal polyps in 15 Miniature Dachshunds.

Authors:  Kenjiro Fukushima; Nozomi Eguchi; Koichi Ohno; Hideyuki Kanemoto; Masashi Takahashi; Hirotaka Igarashi; Aki Ohmi; Ko Nakashima; Hajime Tsujimoto
Journal:  J Vet Med Sci       Date:  2015-10-10       Impact factor: 1.267

6.  A Retrospective Study on the Safety and Efficacy of Leflunomide in Dogs.

Authors:  M Sato; J K Veir; M Legare; M R Lappin
Journal:  J Vet Intern Med       Date:  2017-08-21       Impact factor: 3.333

Review 7.  Canine autoimmune hemolytic anemia: management challenges.

Authors:  James W Swann; Barbara J Skelly
Journal:  Vet Med (Auckl)       Date:  2016-07-26

8.  ACVIM consensus statement on the treatment of immune-mediated hemolytic anemia in dogs.

Authors:  James W Swann; Oliver A Garden; Claire L Fellman; Barbara Glanemann; Robert Goggs; Dana N LeVine; Andrew J Mackin; Nathaniel T Whitley
Journal:  J Vet Intern Med       Date:  2019-03-07       Impact factor: 3.333

Review 9.  Immune-Mediated Central Nervous System Disease-Current Knowledge and Recommendations.

Authors:  Samantha Vitale; Kari Foss
Journal:  Top Companion Anim Med       Date:  2018-12-04

10.  Treatment of canine meningoencephalomyelitis of unknown aetiology with mycophenolate mofetil and corticosteroids: 25 cases (2007-2012).

Authors:  Andrew D Woolcock; Andrea Wang; Allison Haley; Marc Kent; Kate E Creevy; Simon R Platt
Journal:  Vet Med Sci       Date:  2016-02-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.